Mark A Schlossberg - Net Worth and Insider Trading
Mark A Schlossberg Net Worth
The estimated net worth of Mark A Schlossberg is at least $8 Million dollars as of 2024-05-08. Mark A Schlossberg is the SVP - Legal & General Counsel of Cytokinetics Inc and owns about 103,408 shares of Cytokinetics Inc (CYTK) stock worth over $7 Million. Mark A Schlossberg is also the SVP and General Counsel of Impax Laboratories Inc and owns about 73,588 shares of Impax Laboratories Inc (IPXL) stock worth over $1 Million. Details can be seen in Mark A Schlossberg's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Mark A Schlossberg has not made any transactions after 2022-03-15 and currently still holds the listed stock(s).
Transaction Summary of Mark A Schlossberg
Mark A Schlossberg Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark A Schlossberg owns 2 companies in total, including Cytokinetics Inc (CYTK) , and EOM Pharmaceutical Holdings Inc (IMUC) .
Click here to see the complete history of Mark A Schlossberg’s form 4 insider trades.
Insider Ownership Summary of Mark A Schlossberg
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CYTK | Cytokinetics Inc | 2022-03-15 | SVP - Legal & General Counsel |
| IMUC | EOM Pharmaceutical Holdings Inc | 2016-06-17 | director |
Mark A Schlossberg Latest Holdings Summary
Mark A Schlossberg currently owns a total of 2 stocks. Among these stocks, Mark A Schlossberg owns 103,408 shares of Cytokinetics Inc (CYTK) as of March 15, 2022, with a value of $7 Million and a weighting of 83.25%. Mark A Schlossberg also owns 73,588 shares of Impax Laboratories Inc (IPXL) as of September 11, 2015, with a value of $1 Million and a weighting of 16.75%.
Latest Holdings of Mark A Schlossberg
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CYTK | Cytokinetics Inc | 2022-03-15 | 103,408 | 64.71 | 6,691,532 |
| IPXL | Impax Laboratories Inc | 2015-09-11 | 73,588 | 18.30 | 1,346,660 |
Holding Weightings of Mark A Schlossberg
Mark A Schlossberg Form 4 Trading Tracker
According to the SEC Form 4 filings, Mark A Schlossberg has made a total of 4 transactions in Cytokinetics Inc (CYTK) over the past 5 years, including 0 buys and 4 sells. The most-recent trade in Cytokinetics Inc is the sale of 25,196 shares on March 15, 2022, which brought Mark A Schlossberg around $855,656.
According to the SEC Form 4 filings, Mark A Schlossberg has made a total of 0 transactions in Impax Laboratories Inc (IPXL) over the past 5 years. The most-recent trade in Impax Laboratories Inc is the sale of 7,457 shares on September 11, 2015, which brought Mark A Schlossberg around $322,888.
Insider Trading History of Mark A Schlossberg
- 1
Mark A Schlossberg Trading Performance
GuruFocus tracks the stock performance after each of Mark A Schlossberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Mark A Schlossberg is 12.54%. GuruFocus also compares Mark A Schlossberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Mark A Schlossberg within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Mark A Schlossberg's insider trading performs compared to the benchmark.
Performance of Mark A Schlossberg
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.67 | | | | | |
| Relative Return to S&P 500(%) | -4.01 | | | | | |
Mark A Schlossberg Ownership Network
Mark A Schlossberg Owned Company Details
What does Cytokinetics Inc do?
Who are the key executives at Cytokinetics Inc?
Mark A Schlossberg is the SVP - Legal & General Counsel of Cytokinetics Inc. Other key executives at Cytokinetics Inc include SVP Research & Early Dev Fady Ibraham Malik , EVP & Corp. Development & CBO Robert I Blum , and VP & Chief Accounting Officer Robert Wong .
Cytokinetics Inc (CYTK) Insider Trades Summary
Over the past 18 months, Mark A Schlossberg made no insider transaction in Cytokinetics Inc (CYTK). Other recent insider transactions involving Cytokinetics Inc (CYTK) include a net sale of 312,500 shares made by Robert I Blum , a net sale of 151,222 shares made by Fady Ibraham Malik , and a net sale of 27,186 shares made by John T Henderson .
In summary, during the past 3 months, insiders sold 63,714 shares of Cytokinetics Inc (CYTK) in total and bought 0 shares, with a net sale of 63,714 shares. During the past 18 months, 538,266 shares of Cytokinetics Inc (CYTK) were sold and 0 shares were bought by its insiders, resulting in a net sale of 538,266 shares.
Cytokinetics Inc (CYTK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cytokinetics Inc Insider Transactions
Mark A Schlossberg Mailing Address
Above is the net worth, insider trading, and ownership report for Mark A Schlossberg. You might contact Mark A Schlossberg via mailing address: C/o Impax Laboratories, Inc., 30831 Huntwood Avenue, Hayward Ca 94544.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
